Skip to content

Docs (opens in a new tab)Pricing Research Benchmark

Sign in Sign up

A

ACIU

AC Immune S.A.

NASDAQHealthcareBiotechnologyCH

NASDAQ · Healthcare · Biotechnology · CH

$2.86

−2.39%

FinancialsValuationProfitabilityGrowthCapitalMomentum

EarningsOwnershipNewsAnalysis

Research · Sep 3, 2026

ACIU: FY25 Deep Dive

AC Immune FY25 at CHF 4M. NI CHF -67M; EPS CHF -0.67.

The idea engine
for fundamental investors.

Product

Ask drillr Watchlist

Resources

Research Methodology Benchmark Docs (opens in a new tab)

Data parsed from primary filings: SEC EDGAR · EDINET · HKEX · CNINFO · DART. Prices delayed 15 minutes.

Pricing Privacy Terms© 2026 LIL GREBE INC.